{
    "drug_class_values": "alkyl sulfonates , cd22 (clusters of differentiation 22) inhibitors , egfr (epidermal growth factor receptor) inhibitors , detoxifying agents for antineoplastic treatment , other antithrombotic agents , cd38 (clusters of differentiation 38) inhibitors , various therapeutic radiopharmaceuticals , enzymes , other hematological agents , other immunostimulants , various alimentary tract and metabolism products , antivirals , epidermal growth factor receptor (egfr) tyrosine kinase inhibitors , bcr-abl tyrosine kinase inhibitors , other immunosuppressants , selective immunosuppressants , other plant alkaloids and natural products , other hormone antagonists and related agents , preparations increasing uric acid excretion , other protein kinase inhibitors , vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors , proteasome inhibitors , anti-androgens , antineoplastic cell and gene therapy , fourth-generation cephalosporins , vegf/vegfr (vascular endothelial growth factor / -receptor) inhibitors , cd20 (clusters of differentiation 20) inhibitors , anti-estrogens , nan , antineovascularisation agents , her2 (human epidermal growth factor receptor 2) inhibitors , other monoclonal antibodies and antibody drug conjugates , hedgehog pathway inhibitors , other antianemic preparations , combinations of antineoplastic agents , pd-1/pd-l1 (programmed cell death protein 1/death ligand 1) inhibitors , combinations of monoclonal antibodies and antibody drug conjugates , anaplastic lymphoma kinase (alk) inhibitors , b-raf serine-threonine kinase (braf) inhibitors , poly (adp-ribose) polymerase (parp) inhibitors , fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors , phosphatidylinositol-3-kinase (pi3k) inhibitors , other antineoplastic agents , pyrimidine analogues , janus-associated kinase (jak) inhibitors , bruton's tyrosine kinase (btk) inhibitors , cyclin-dependent kinase (cdk) inhibitors , colony stimulating factors , isocitrate dehydrogenase (idh) inhibitors , other drugs affecting bone structure and mineralization , aromatase inhibitors , monoclonal antibodies , interleukin inhibitors , interferons , human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors , histone deacetylase (hdac) inhibitors , mitogen-activated protein kinase (mek) inhibitors"
    ,"drug_indication_values":  "hidradenitis suppurativa , small cell lung cancer , neuromyelitis optica spectrum disorder , bullous pemphigoid , mantle cell lymphoma , gastric or gastro-esophageal junction adenocarcinoma , merkel cell carcinoma , solid tumors , basal cell carcinoma , b-cell precursor acute lymphoblastic leukemia , uveal melanoma , non-squamous non-small cell lung cancer , tumor mutational burden-high solid tumors , advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer , light chain (al) amyloidosis , crohn's disease , osteoporosis , urothelial carcinoma , eosinophilic esophagitis , polymyalgia rheumatica , cutaneous t-cell lymphoma , non-muscle invasive bladder cancer , methotrexate toxicity , metastatic gastric adenocarcinoma , neovascular age-related macular degeneration , kaposi sarcoma , spinal muscular atrophy , gastric cancer , esophageal squamous cell carcinoma , gastric or gastroesophageal junction adenocarcinoma , gastrointestinal stromal tumor , endometrial cancer , ulcerative colitis , giant cell tumor of bone , melanoma , non-myeloid malignancies , marginal zone lymphoma , synovial sarcoma , metastatic colorectal cancer , pheochromocytoma or paraganglioma , biliary tract cancer , tenosynovial giant cell tumor , sickle cell disease , lupus nephritis , low-grade glioma , advanced systemic mastocytosis , chronic lymphocytic leukemia or small lymphocytic lymphoma , neuroendocrine tumors , acute lymphoblastic leukemia , cytokine release syndrome , neuroblastoma , macular edema , colorectal cancer , nonmuscle invasive bladder cancer , chronic obstructive pulmonary disease , cholangiocarcinoma , solid tumors with ntrk gene fusion , esophageal cancer , systemic juvenile idiopathic arthritis , hypercalcemia of malignancy , myelodysplastic syndromes with ring sideroblasts or myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis , differentiated thyroid cancer , mast cell leukemia , malignant pleural mesothelioma , medullary thyroid cancer , squamous cell carcinoma of the oral cavity , large b-cell lymphoma , small lymphocytic lymphoma , enthesitis-related arthritis , mismatch repair deficient recurrent or advanced solid tumors , von hippel-lindau disease , hepatic veno-occlusive disease (vod) / sinusoidal obstruction syndrome (sos) , β-thalassemia , microsatellite instability-high or mismatch repair deficient colorectal cancer , alzheimer's disease , indolent systemic mastocytosis , aggressive systemic mastocytosis , acute myeloid leukemia , squamous non-small cell lung cancer , pancreatic cancer , epithelioid sarcoma , prurigo nodularis , atopic dermatitis , nasopharyngeal carcinoma , autologous hematopoietic progenitor cell mobilization , achondroplasia , pediatric low-grade glioma , plaque psoriasis , neurofibromatosis type 1 , beta thalassemia , breast cancer , severe chronic neutropenia , myelodysplastic syndromes , uncomplicated urinary tract infection , granulomatosis with polyangiitis and microscopic polyangiitis , myeloid/lymphoid neoplasms , rheumatoid arthritis , duchenne muscular dystrophy , bladder cancer , histiocytic neoplasms , non-hodgkin's lymphoma , waldenström's macroglobulinemia , alveolar soft part sarcoma , polyarticular juvenile idiopathic arthritis , hematopoietic subsyndrome of acute radiation syndrome , chronic lymphocytic leukemia / small lymphocytic lymphoma , myelodysplastic syndrome , cervical cancer , asthma , diffuse large b-cell lymphoma and high-grade b-cell lymphoma , cognitive impairment , multicentric castleman's disease , beta-thalassemia , chronic myeloid leukemia , liposarcoma , transthyretin-mediated amyloidosis , non-radiographic axial spondyloarthritis , chronic lymphocytic leukemia , chronic graft-versus-host disease , glioblastoma , chronic rhinosinusitis with nasal polyps , renal cell carcinoma , bone loss due to androgen deprivation therapy , lung cancer , desmoid tumor , giant cell arteritis , glucocorticoid-induced osteoporosis , lymphoblastic lymphoma , non-myeloid malignancy , hereditary transthyretin-mediated amyloidosis , ovarian cancer , triple-negative breast cancer , myelofibrosis , coronavirus disease 2019 , metastatic renal cell carcinoma , friedreich's ataxia , grade 2 astrocytoma or oligodendroglioma , ankylosing spondylitis , carcinoid syndrome diarrhea , waldenström’s macroglobulinemia , head and neck squamous cell carcinoma , leiomyosarcoma , prostate cancer , acute graft versus host disease , bone metastases from solid tumors , polycythemia vera , endometrial carcinoma , chronic myelogenous leukemia , diabetic retinopathy , cutaneous squamous cell carcinoma , coronary artery disease , systemic mastocytosis with associated hematological neoplasm , squamous cell carcinoma of the head and neck , recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer , multiple sclerosis , anaplastic thyroid cancer , bone loss due to aromatase inhibitor therapy , follicular lymphoma , high-risk smoldering multiple myeloma , multiple myeloma , microsatellite instability-high or mismatch repair deficient solid tumors , gastroenteropancreatic neuroendocrine tumors , thyroid cancer , hepatocellular carcinoma , epithelial ovarian cancer , peripheral t-cell lymphoma , urothelial cancer , nonmyeloid malignancies , diffuse large b-cell lymphoma , philadelphia chromosome-positive acute lymphoblastic leukemia , squamous cell carcinoma of the anal canal , blastic plasmacytoid dendritic cell neoplasm , chronic lymphocytic leukemia/small lymphocytic lymphoma , chronic spontaneous urticaria , diabetic macular edema , non-small cell lung cancer , psoriatic arthritis , acute leukemia , pemphigus vulgaris , hematopoietic syndrome of acute radiation syndrome"
}
      